cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of by 78c Enhanced NAD+, Alleviated Inflammation, Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens CD38-Induced Metabolic Dysfunction Primes Multiple
CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship Targeting CD38 in Neoplasms and Non Cancer Diseases Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect A systems approach to NAD+ restoration ScienceDirect CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





